Coal India advances Technology-led Diversification Across Energy & Minerals (See 'Corp Brief') Digital India RISC-V Grand Challenge under C2S Programme awarded to 3 teams (See 'Corp Brief') IBC - Arrangement of funds to enable corporate debtor to clear its liabilities, coupled with transfer of funds from cooperative bank loan account of applicant directly to bank, is not valid loan disbursement under IBC: NCLT (See 'Legal Desk') Vaishnaw highlights ISM 2.0, indigenous design, manufacturing, talent and India's emergence (See 'Corp Brief') SEBI - SEBI, acting as statutory market regulator, is duty-bound to issue a reasoned, speaking order when a decision carries serious civil consequences for acquirer, target company & investors: SAT (See 'Legal Desk') An unsuccessful 'success fee' litigation (See CORP EINSICHT) Centre commemorates World Patient Safety Day 2026 at NIHFW (See 'Corp Brief') BIMSTEC Energy Centre organises 5-Day Capacity Building Programme (See 'Corp Brief') Scindia inaugurates Renovated Guna Head Post Office in MP (See 'Corp Brief') SEBI - Where material on record discloses need for deeper scrutiny, re-appreciation, review or reconsideration of evidence, leave ought to be granted & the appeal should thereafter be decided on merits: HC (See 'Legal Desk') CCI nod for acquisition of equity of Great White Global by ISAF III Onshore Fund (See 'Corp Brief') From Ink and Ledger to Cloud and Cipher: The Bankers' Books Evidence Act, 2026 - A Critical Appraisal of India's Digital Evidentiary Revolution (See CORP EINSICHT) A&C Act - Question whether particular claim is covered by, or falls outside excepted matters clause of works contract is matter squarely within competence of Arbitral Tribunal u/s 16 of Arbitration and Conciliation Act: SC (See 'Legal Desk') CCI approves acquisition of addl share in Azure Power Global by OMERS Infra (See 'Corp Brief') Beneficiaries express confidence in government policies for e-mobility (See 'Corp Brief') Competition Act - Regulatory decisions taken in exercise of statutory powers not subject to review by CCI; authority concerned is not amenable to scrutiny u/s 4 of Competition Act: CCI (See 'Legal Desk') Semicon 2.0 mission to focus semiconductor design & fabrication; to create 1 lakh jobs (See 'Corp Brief') NLMC to host investor meets ahead of RINL land e-auction (See 'Corp Brief') SEBI - Penalty order under SEBI (PFUTP) Regulations unsustainable where foundational findings regarding volume of manually deleted orders & manipulative intent are perverse & contrary to the record: SAT (See 'Legal Desk') Govt reviews Use of Steel from Ship Recycling to Boost Steel Manufacturing (See 'Corp Brief') Inaugural PDUNASS–GNLU Executive Program on Labour Law concludes at Gandhinagar (See 'Corp Brief') Capital Market - Release of escrow amount maintained for buyback does not bar separate inquiry into alleged fraud under PFUTP Regulations: SC (See 'Legal Desk')

Print

Pharmaceuticals & Medical Devices Bureau has partnered to open Jan Aushadhi Kendras

Published: Dec 11, 2024

By TIOLCorplaws News Service

NEW DELHI, DEC 11, 2024: TO increase access to medicines in rural areas, the Pharmaceuticals & Medical Devices Bureau of India, the implementing agency of PMBJP has partnered with the Cooperative sector to open Jan Aushadhi Kendras through Primary Agriculture Cooperative Societies (PACS). Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS.

The government launched Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) under which Jan Aushadhi Kendras (JAKs) are opened by inviting applications from individual entrepreneurs, NGOs, Societies, Trusts, Firms, and Private Companies etc. While opening these Kendras, 1 km distance is maintained between two Kendras. Online applications have been invited from all districts through the website www.janaushadhi.gov.in. This process facilitates opening of Jan Aushadhi Kendras (JAKs) at the block as well as at the district level. There is no State/UT-wise target for opening of new JAKs.

Jan Aushadhi medicines are being supplied to Central Government Health Scheme dispensaries, various AIIMS, Hospitals, etc. based on their demand. All JAK owners are eligible for an incentive @ 20% of monthly purchases made by them, subject to a ceiling of Rs. 20,000/- per month. In addition, a one-time incentive of Rs. 2.00 lakh is provided to the JAKs opened in North-Eastern States, Himalayan areas, Island territories, and areas mentioned as aspirational districts by NITI Aayog or opened by women entrepreneurs, ex-servicemen, Divyang, SC & ST in the form of support towards furniture, computers, refrigerators, and other fixtures. For operational support, there are State-wise Marketing Officers who support applicants in obtaining Drug licenses and supply of medicines to JAKs by the distributor and warehouse network of Jan Aushadhi.

This information was given by the Union Minister of State for Chemicals and Fertilizers Anupriya Patel in Rajya Sabha in a written reply to a question yesterday.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.